Prevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Study

dc.contributor.authorTuncer, Tiraje
dc.contributor.authorGilgil, Erdal
dc.contributor.authorKacar, Cahit
dc.contributor.authorKurtais, Yesim
dc.contributor.authorKutlay, Sehim
dc.contributor.authorButun, Bulent
dc.contributor.authorYalcin, Peyman
dc.date.accessioned2024-04-24T17:27:58Z
dc.date.available2024-04-24T17:27:58Z
dc.date.issued2018
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjectives: This study aims to estimate the prevalence of rheumatoid arthritis (RA) and spondyloarthritis (SpA) in Turkey using the same telephone questionnaire developed for screening RA and SpA in France and used in Serbia and Lithuania. Material and methods: The study was performed in two steps. In step I, the French questionnaire was translated into Turkish and validated through a group of 200 patients (80 males, 120 females; mean age 44.0 +/- 13.1 years; range, 19 to 75 years) followed up at the rheumatology departments of University Hospitals in Antalya and Ankara. In step II, the validated Turkish questionnaire was administered face-to-face to randomly selected 4,012 subjects (1,670 males, 2,342 females; mean age 41.5 +/- 16.8 years; range, 16 to 97 years) by trained general practitioners across the country, in 25 provinces for case detection. The subjects who were suspected of having RA or SpA in accordance with the questionnaire were invited to the nearest university hospital for rheumatologic examination in order to confirm the diagnosis. Results: In step II, a total of 25 subjects (2 males, 23 females) were diagnosed as RA. The standardized RA prevalence for the general population of Turkey was calculated as 0.56% (95% confidence interval [CI]; 0.33-0.79), 0.10% (95% CI; -0.05-0.25) for males and 0.89% (95% CI; 0.51-1.27) for females. A total of 18 subjects (3 males, 15 females) were diagnosed as SpA. The standardized SpA prevalence for the general population of Turkey was 0.46% (95% CI; 0.25-0.67), 0.17% (95% CI; -0.03-0.37) for males and 0.65% (95% CI; 0.32-0.98) for females. The prevalence of RA was highest in the Northern region (2.00%) and the prevalence of SpA was highest in the Central region (1.49%). Conclusion: The prevalences of RA and SpA in Turkey are close to each other and there are significant inter-regional variations in prevalences of both RA and SpA.en_US
dc.description.sponsorshipSanofi Health Products Company, Turkeyen_US
dc.description.sponsorshipThis survey was supported with an unconditional Grant to Turkish League Against Rheumatism from Sanofi Health Products Company (former Aventis), Turkey. The secretary expenses was covered by EULAR Standing Committee on Epidemiology and Health Services Research.en_US
dc.identifier.doi10.5606/ArchRheumatol.2018.6480
dc.identifier.endpage136en_US
dc.identifier.issn2148-5046
dc.identifier.issn1309-0283
dc.identifier.issue2en_US
dc.identifier.pmid30207568
dc.identifier.startpage128en_US
dc.identifier.trdizinid289859
dc.identifier.urihttps://doi.org/10.5606/ArchRheumatol.2018.6480
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/289859
dc.identifier.urihttps://hdl.handle.net/11468/20273
dc.identifier.volume33en_US
dc.identifier.wosWOS:000435672000003
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTurkish League Against Rheumatismen_US
dc.relation.ispartofArchives of Rheumatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEpidemiologyen_US
dc.subjectPrevalenceen_US
dc.subjectRheumatoid Arthritisen_US
dc.subjectSpondyloarthritisen_US
dc.titlePrevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Studyen_US
dc.titlePrevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Study
dc.typeArticleen_US

Dosyalar